Prognostic Factors in Hodgkin Lymphoma

Hodgkin lymphoma (HL) is among the neoplastic diseases that has the best long-term outcome after cytotoxic treatment. Cure rates approach 80–90%; however, 15–20% of patients will be resistant to therapy (primary refractory) or relapse after treatment. Prognostic factors should help to stratify treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuccaro, Annarosa, Bartolomei, Francesca, Cupelli, Elisa, Galli, Eugenio, Giachelia, Manuela, Hohaus, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103502/
https://www.ncbi.nlm.nih.gov/pubmed/25045461
http://dx.doi.org/10.4084/MJHID.2014.053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103502/
https://www.ncbi.nlm.nih.gov/pubmed/25045461
http://dx.doi.org/10.4084/MJHID.2014.053

Ejemplares similares